JP2007238509A - Agent for ameliorating skin symptom, supplement, food, beverage and pharmaceutical for ameliorating skin symptom containing the same - Google Patents

Agent for ameliorating skin symptom, supplement, food, beverage and pharmaceutical for ameliorating skin symptom containing the same Download PDF

Info

Publication number
JP2007238509A
JP2007238509A JP2006063727A JP2006063727A JP2007238509A JP 2007238509 A JP2007238509 A JP 2007238509A JP 2006063727 A JP2006063727 A JP 2006063727A JP 2006063727 A JP2006063727 A JP 2006063727A JP 2007238509 A JP2007238509 A JP 2007238509A
Authority
JP
Japan
Prior art keywords
skin
extract
improving
cimicifuga racemosa
skin symptom
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2006063727A
Other languages
Japanese (ja)
Inventor
Isao Nadaoka
勲 灘岡
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asahi Breweries Ltd
Original Assignee
Asahi Breweries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asahi Breweries Ltd filed Critical Asahi Breweries Ltd
Priority to JP2006063727A priority Critical patent/JP2007238509A/en
Publication of JP2007238509A publication Critical patent/JP2007238509A/en
Withdrawn legal-status Critical Current

Links

Images

Landscapes

  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Non-Alcoholic Beverages (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

<P>PROBLEM TO BE SOLVED: To provide an agent for ameliorating skin symptoms, a supplement for ameliorating skin symptoms, food for ameliorating skin symptoms, beverage for ameliorating skin symptoms, a pharmaceutical agent for ameliorating skin symptoms and a skin cosmetic material excellent in skin amelioration effect and safe when applied to the skin. <P>SOLUTION: The agent for ameliorating skin symptoms contains an extract of Cimicifuga recemosa as an active ingredient. The supplement for ameliorating skin symptoms containing the extract of Cimicifuga recemosa as an active ingredient, the food for ameliorating skin symptoms, the beverage for ameliorating skin symptoms, the skin cosmetic material and the pharmaceutical agent for ameliorating skin symptoms containing the extract of Cimicifuga recemosa as an active ingredient are provided. <P>COPYRIGHT: (C)2007,JPO&INPIT

Description

本発明は、天然物由来の肌症状改善剤、それを含む肌症状改善用のサプリメント、食品、飲料及び医薬に関するものである。   The present invention relates to a natural product-derived skin symptom improving agent, a supplement for improving skin symptom containing the same, food, beverage and medicine.

肌のかさつき、くすみ、しわ等の肌症状を改善するために、従来から各種の天然物由来の成分を配合した美容飲食品や皮膚化粧料が提案されている。   In order to improve skin symptoms such as skin roughness, dullness, and wrinkles, beauty foods and drinks and skin cosmetics containing various natural products have been proposed.

例えば、布渣葉抽出を含む皮膚化粧料及び美容用飲食品(特許文献1)、スフィンゴエミリンを有効成分とする美肌剤(特許文献2)、黒米又は黒米麹の抽出物を配合した美肌組成物(特許文献3)、カウレルパラセモサ藻類抽出からなる細胞賦活剤、皮膚外用剤及び食品(特許文献4)、卵殻膜又はその加水分解物を含有する経口用肌改善剤及び肌改善用食品組成物(特許文献5)、柿の葉又は柿の葉抽出物を含有する肌の乾燥状態の予防又は改善用食品(特許文献6)、ライチ種子エキスを配合した美肌用組成物(特許文献7)、シソ、ラカンの抽出物を含有するストレスによる肌荒れ予防改善剤、化粧料組成物及び飲食品(特許文献8)及びグアガム酵素部分分解物を含有する美肌飲食品用組成物(特許文献9)などが知られている。
特開2006−45092公報 特開2005−281257公報 特開2004−99578公報 特開2004−10559公報 特開2003−246741公報 特開2003−135026公報 特開2003−63926公報 特開2001−139083公報 特開2000−125828公報
For example, a skin beautifying composition comprising a skin cosmetic containing a leaf leaf extract and a cosmetic food and drink (Patent Document 1), a skin beautifying agent containing Sphingoemilin (Patent Document 2), and an extract of black rice or black rice bran. (Patent Document 3), Cell Activator consisting of Kaurell paracemosa algae extract, Skin external preparation and food (Patent Document 4), Oral skin improving agent and food composition for skin improvement containing eggshell membrane or hydrolyzate thereof (Patent Literature 5), a food for preventing or improving dry skin containing persimmon leaves or persimmon leaf extract (Patent Literature 6), and a composition for beautifying skin containing litchi seed extract (Patent Literature 7) An agent for improving the prevention of rough skin caused by stress, an extract containing perilla and lacan, a cosmetic composition and a food and drink (Patent Document 8), and a composition for beautifying skin food and drink containing a partial degradation product of guar gum enzyme (Patent Document 9) It has been known.
JP 2006-45092 A JP-A-2005-281257 JP 2004-99578 A JP 2004-10559 A JP 2003-246741 A JP 2003-135026 A JP 2003-63926 A JP 2001-139083 A JP 2000-125828 A

しかしながら従来技術の肌症状改善剤や肌症状改善用飲食品は、十分な効果を発揮するとはいえなかった。本発明が解決しようとする課題は、経口摂取しても安全で、効果の優れた肌症状改善剤、肌症状改善用サプリメント、肌症状改善用食品、肌症状改善用飲料及び肌症状改善用医薬、皮膚に塗布しても安全で、肌症状改善効果の優れた皮膚化粧料を提供することにある。   However, it cannot be said that the skin symptom improving agent and food / beverage products for improving skin symptom of the prior art show sufficient effects. The problem to be solved by the present invention is a skin symptom improving agent, a supplement for improving skin symptom, a food for improving skin symptom, a beverage for improving skin symptom, a drug for improving skin symptom, and a medicine that is safe even when taken orally An object of the present invention is to provide a skin cosmetic that is safe to apply to the skin and has an excellent effect on improving skin symptoms.

本発明者らは、上記課題を解決すべく、安全な植物の中から肌症状改善作用を有するものについて鋭意研究を重ねた結果、シミシフーガ ラセモサ(Cimicifuga racemosa)からの抽出物が有効であることを見出し、本発明を完成するに至った。   In order to solve the above-mentioned problems, the present inventors have conducted extensive research on a safe plant having a skin symptom-improving action. As a result, it has been found that an extract from Cimicifuga racemosa is effective. The headline and the present invention were completed.

本発明は以下の記載を要旨とするものである。
(1) シミシフーガ ラセモサ(Cimicifuga racemosa)抽出物を有効成分として含有することを特徴とする肌症状改善剤。
(2) シミシフーガ ラセモサ(Cimicifuga racemosa)抽出物を配合したことを特徴とする肌症状改善用サプリメント。
(3) シミシフーガ ラセモサ(Cimicifuga racemosa)抽出物を配合したことを特徴とする肌症状改善用食品。
(4) シミシフーガ ラセモサ(Cimicifuga racemosa)抽出物を配合したことを特徴とする肌症状改善用飲料。
(5) シミシフーガ ラセモサ(Cimicifuga racemosa)抽出物を配合したことを特徴とする皮膚化粧料。
(6) シミシフーガ ラセモサ(Cimicifuga racemosa)抽出物を有効成分として含有することを特徴とする肌症状改善用医薬。
The present invention is summarized as follows.
(1) A skin symptom improving agent comprising a Cimicifuga racemosa extract as an active ingredient.
(2) A supplement for improving skin symptoms, characterized by blending Cimicifuga racemosa extract.
(3) A food for improving skin symptoms, characterized by containing an extract of Cimicifuga racemosa.
(4) A skin symptom-improving drink characterized by containing an extract of Cimicifuga racemosa.
(5) A skin cosmetic characterized by containing an extract of Cimicifuga racemosa.
(6) A medicament for improving skin symptoms, comprising an extract of Cimicifuga racemosa as an active ingredient.

本発明の肌症状改善剤は、シミシフーガ ラセモサ(Cimicifuga racemosa)抽出物を有効成分として含有することにより、安全性が高く、優れた肌症状改善作用が発揮される。   The skin symptom improving agent of the present invention contains a Cimicifuga racemosa extract as an active ingredient, so that it has high safety and exhibits an excellent skin symptom improving action.

また、本発明の肌症状改善用サプリメント、肌症状改善用食品及び肌症状改善用飲料は、シミシフーガ ラセモサ(Cimicifuga racemosa)抽出物を配合することにより、経口摂取しても安全で肌症状を改善することができる。   In addition, the skin symptom improving supplement, the skin symptom improving food and the skin symptom improving beverage of the present invention are safe even when taken orally and improve the skin symptom by incorporating the Cimicifuga racemosa extract. be able to.

本発明の皮膚化粧料は、シミシフーガ ラセモサ(Cimicifuga racemosa)抽出物を配合することにより、皮膚に塗布しても安全で肌症状を改善することができる。   The skin cosmetic of the present invention can be safely applied and improved on skin symptoms even when applied to the skin by blending Cimicifuga racemosa extract.

さらに、本発明の肌症状改善用医薬は、シミシフーガ ラセモサ(Cimicifuga racemosa)抽出物を有効成分として含有することにより、安全性が高く、効果的に肌症状の悪化を予防したり改善することができる。   Furthermore, the medicament for improving skin symptoms according to the present invention contains a Cimicifuga racemosa extract as an active ingredient, which is highly safe and can effectively prevent or improve the deterioration of skin symptoms. .

本発明の肌症状改善剤は、シミシフーガ ラセモサ(Cimicifuga racemosa)抽出物を有効成分として含有することを特徴とするものである。   The skin symptom improving agent of the present invention is characterized by containing an extract of Cimicifuga racemosa as an active ingredient.

シミシフーガ ラセモサ(Cimicifuga racemosa)抽出物とは、シミシフーガ ラセモサ(Cimicifuga racemosa)を抽出原料として得られる抽出液はもちろんのこと、該抽出液の希釈液や濃縮液であってもよい。また、抽出液を公知の手段で乾燥した乾燥物であってもよい。   The Cimicifuga racemosa extract may be an extract obtained from Cimicifuga racemosa as a raw material for extraction, as well as a diluted solution or a concentrated solution of the extract. Moreover, the dried material which dried the extract with the well-known means may be sufficient.

抽出原料となるシミシフーガ ラセモサ(Cimicifuga racemosa)とは、慣用名をブラックコホシュというキンポウゲ科サラシナショウマ属の草木である。シミシフーガ ラセモサ(Cimicifuga racemosa)は、古くから北米のインディアン達によって痛み止めや更年期障害の改善を目的に食され、現在も食用ハーブとして欧米で流通している。シミシフーガ ラセモサ(Cimicifuga racemosa)の成分の一つであるシミシフギンは急激なエストロゲンの減少を抑えて、更年期障害の症状を和らげることが知られている。シミシフーガ ラセモサ(Cimicifuga racemosa)抽出物の使用については、心臓血管疾患・アテローム性動脈硬化症・骨粗鬆症、月経困難症または月経前症候群および更年期障害の治療および/又は予防、例えば一過性熱感の予防又は軽減のためのエストロゲン型期間選択制薬剤として開示されている(特表2002-506827号公報)。また、肌あれを含む月経前症候群や更年期障害の諸症状改善のためのシミシフーガ ラセモサ(Cimicifuga racemosa)抽出物を含む組成物が開示されている(特開2004-262922号公報、特開2004-2335号公報)。しかし、健常人の肌症状を改善する効果については言及されていない。   Cimicifuga racemosa, which is the raw material for extraction, is a plant belonging to the genus Sarcophaceae, commonly known as Black Kohosh. Simicifuga racemosa has long been eaten by North American Indians for the purpose of pain relief and improvement of menopause, and is still distributed in Europe and America as an edible herb. Shimisifugin, one of the components of Cimicifuga racemosa, is known to suppress the rapid decrease of estrogen and relieve symptoms of menopause. For the use of Cimicifuga racemosa extract, the treatment and / or prevention of cardiovascular disease, atherosclerosis, osteoporosis, dysmenorrhea or premenstrual syndrome and climacteric disorders, for example prevention of transient heat sensation Or it is disclosed as an estrogen type period selective drug for reduction (Japanese Patent Publication No. 2002-506827). Further, a composition containing an extract of Cimicifuga racemosa for improving various symptoms of premenstrual syndrome including skin roughness and menopause is disclosed (JP 2004-262922 A, JP 2004-2335 A). Issue gazette). However, there is no mention of the effect of improving skin symptoms in healthy people.

抽出原料となるシミシフーガ ラセモサ(Cimicifuga racemosa)の抽出部位は特に限定されないが、トリテルペン配糖体類の含有量が多い根茎部が好ましい。   The extraction site of Cimicifuga racemosa, which is the raw material for extraction, is not particularly limited, but a rhizome with a high content of triterpene glycosides is preferable.

抽出方法は特に限定されないが、例えば抽出溶媒を用いる溶媒抽出法や、超臨界抽出法が挙げられる。   The extraction method is not particularly limited, and examples thereof include a solvent extraction method using an extraction solvent and a supercritical extraction method.

溶媒抽出法に用いる溶媒としては、水若しくは親水性溶媒又はこれらの混合物を挙げることができる。   Examples of the solvent used in the solvent extraction method include water, a hydrophilic solvent, and a mixture thereof.

溶媒抽出法において、抽出溶媒に用いる水は特に限定されるものではないが、例えば水道水、蒸留水、純水、イオン交換水等を挙げることができる。   In the solvent extraction method, water used for the extraction solvent is not particularly limited, and examples thereof include tap water, distilled water, pure water, and ion exchange water.

溶媒抽出法において、抽出溶媒に用いる親水性溶媒としては、例えば、メタノール、エタノール、プロピルアルコール、イソプロピルアルコール等の低級アルコール、アセトン、メチルエチルケトン等の低級脂肪族ケトン、1,3−ブチレングリコール、プロピレングリコール、グリセリン等の多価アルコールを挙げることができる。   Examples of the hydrophilic solvent used as the extraction solvent in the solvent extraction method include lower alcohols such as methanol, ethanol, propyl alcohol, and isopropyl alcohol, lower aliphatic ketones such as acetone and methyl ethyl ketone, 1,3-butylene glycol, and propylene glycol. And polyhydric alcohols such as glycerin.

溶媒抽出法における混合溶媒は、水と親水性溶媒を適宜混合して用いるものであるが、例えば50%エタノール溶液が、トリテルペン配糖体類を効率よく抽出できるので好ましい。   As the mixed solvent in the solvent extraction method, water and a hydrophilic solvent are appropriately mixed and used. For example, a 50% ethanol solution is preferable because triterpene glycosides can be efficiently extracted.

溶媒抽出法により抽出する場合は、例えば、抽出原料となるシミシフーガ ラセモサ(Cimicifuga racemosa)の根茎部を乾燥した後、そのまま、又は粉砕し、抽出溶媒による抽出処理を行えばよい。抽出は室温もしくは加熱下に行えばよい。   In the case of extraction by a solvent extraction method, for example, after drying the rhizome part of Cimicifuga racemosa as an extraction raw material, it may be subjected to extraction treatment with an extraction solvent as it is or after pulverization. Extraction may be performed at room temperature or under heating.

超臨界抽出法は、31℃、7.4MPa以上の超臨界状態の二酸化炭素流体を用いて抽出する抽出法であり、低温で効率的に有効成分を抽出することができる。   The supercritical extraction method is an extraction method that uses a carbon dioxide fluid in a supercritical state at 31 ° C. and 7.4 MPa or more, and can extract effective components efficiently at a low temperature.

本発明の肌状態改善剤により、悪化の予防若しくは改善される肌症状とは、「しっとり感」、「さっぱり感」、「べたつき感」、「お化粧のノリ」、「かさつき」、「くすみ」、「シミ・ソバカス」、「しわ」、「透明感」、「吹き出物」、「肌のかたさ」、「肌のキメ」、「張り・弾力」、「べたつき」等である。   The skin symptoms that are prevented or improved by the skin condition improving agent of the present invention are “moist feeling”, “freshness”, “tackiness”, “make-up feeling”, “smoothness”, “dullness” ”,“ Spots ”,“ wrinkles ”,“ transparency ”,“ pimple ”,“ skin hardness ”,“ skin texture ”,“ tension / elasticity ”,“ stickiness ”, and the like.

肌症状改善剤をサプリメントとするには、公知の方法により剤型化すればよい。本発明の肌症状改善剤をサプリメントとする場合の剤形は特に限定されないが、例えば錠剤、散剤、細粒剤、顆粒剤、カプセル剤、丸剤等の固形製剤、水剤、懸濁剤、シロップ剤、乳剤等の液剤等の経口投与剤が挙げられる。この経口投与剤は、形態に応じて当分野において通常用いられる賦形剤、崩壊剤、結合剤、滑沢剤、界面活性剤、アルコール類、水、水溶性高分子、甘味料、矯味剤、酸味料、薬剤用担体等を添加して通常使用されている方法によって製造することができる。   In order to use the skin symptom improving agent as a supplement, it may be formulated by a known method. The dosage form when the skin symptom improving agent of the present invention is used as a supplement is not particularly limited, but for example, solid preparations such as tablets, powders, fine granules, granules, capsules, pills, liquid preparations, suspensions, Oral administration agents such as syrups and liquids such as emulsions may be mentioned. This orally administered agent includes excipients, disintegrants, binders, lubricants, surfactants, alcohols, water, water-soluble polymers, sweeteners, flavoring agents, It can be produced by a commonly used method by adding a sour agent, a pharmaceutical carrier and the like.

肌症状改善剤をサプリメントとして摂取するには、シミシフーガ ラセモサ(Cimicifuga racemosa)抽出物を乾燥重量として成人一人当たり0.3〜200mg摂取すればよい。   In order to ingest the skin symptom-improving agent as a supplement, 0.3 to 200 mg per adult may be ingested as a dry weight of Cimicifuga racemosa extract.

シミシフーガ ラセモサ(Cimicifuga racemosa)抽出物を飲料に配合することにより肌症状改善用飲料を製造することができる。飲料としては、例えば果実ジュース、野菜ジュース、麦茶、緑茶、紅茶、コーヒー、ヨーグルト飲料、乳酸菌飲料、低アルコール飲料等を挙げることができる。シミシフーガ ラセモサ(Cimicifuga racemosa)抽出物を配合した飲料を飲むことにより、安全に上述の肌症状が予防若しくは改善される。   A skin symptom-improving beverage can be produced by blending a Cimicifuga racemosa extract into a beverage. Examples of the beverage include fruit juice, vegetable juice, barley tea, green tea, black tea, coffee, yogurt beverage, lactic acid bacteria beverage, and low alcohol beverage. By drinking a beverage containing Cimicifuga racemosa extract, the above skin symptoms can be safely prevented or improved.

また、シミシフーガ ラセモサ(Cimicifuga racemosa)抽出物を食品に配合することにより肌症状改善用食品を製造することができる。食品とは、例えば発酵乳・チーズ・バターなどの乳製品、飴・クッキー・チューインガム・バターケーキなどの菓子、パン類
等を挙げることができる。シミシフーガ ラセモサ(Cimicifuga racemosa)抽出物を配合した食品を摂食することにより、安全に上述の肌症状が予防若しくは改善される。
Moreover, the food for skin symptom improvement can be manufactured by mix | blending a Cimicifuga racemosa extract with a foodstuff. Examples of the food include dairy products such as fermented milk, cheese, and butter, confectionery such as rice cake, cookies, chewing gum, and butter cake, and breads. By eating foods containing Cimicifuga racemosa extract, the above skin symptoms can be safely prevented or improved.

さらに、シミシフーガ ラセモサ(Cimicifuga racemosa)抽出物を配合することにより皮膚化粧料を製造することができる。皮膚化粧料とは、例えば、化粧水、乳液、化粧クリーム、ファンデーション、ほお紅、白粉等を挙げることができる。皮膚化粧料は常法に従って調製すればよい。シミシフーガ ラセモサ(Cimicifuga racemosa)抽出物を配合した皮膚化粧料を用いることにより、上述の肌症状が予防若しくは改善される。シミシフーガ ラセモサ(Cimicifuga racemosa)抽出物は天然物由来の成分であり、皮膚に塗布しても安全である。   Furthermore, skin cosmetics can be manufactured by mix | blending a Cimicifuga racemosa extract. Examples of skin cosmetics include skin lotion, milky lotion, cosmetic cream, foundation, blusher, and white powder. The skin cosmetic may be prepared according to a conventional method. By using a skin cosmetic containing a Cimicifuga racemosa extract, the above-mentioned skin symptoms are prevented or improved. Cimicifuga racemosa extract is a natural ingredient and is safe to apply to the skin.

さらにまた、シミシフーガ ラセモサ(Cimicifuga racemosa)抽出物を有効成分とする肌症状改善用医薬を製造することができる。本発明の肌症状改善用医薬品の剤形は特に限定されないが、例えば錠剤、散剤、細粒剤、顆粒剤、カプセル剤、丸剤等の固形製剤、水剤、懸濁剤、シロップ剤、乳剤等の液剤等の経口投与剤が挙げられる。この経口投与剤は、形態に応じて当分野において通常用いられる賦形剤、崩壊剤、結合剤、滑沢剤、界面活性剤、アルコール類、水、水溶性高分子、甘味料、矯味剤、酸味料、薬剤用担体等を添加して通常使用されている方法によって製造することができる。シミシフーガ ラセモサ(Cimicifuga racemosa)抽出物を有効成分とする肌症状改善用医薬を服用することにより、上述の肌症状が予防若しくは改善される。肌症状改善剤用医薬の服用量は、シミシフーガ ラセモサ(Cimicifuga racemosa)抽出物を乾燥重量で成人一人当たり0.3〜200mg摂取すればよい。   Furthermore, a skin symptom-improving medicament comprising the Cimicifuga racemosa extract as an active ingredient can be produced. The dosage form of the pharmaceutical agent for improving skin symptoms of the present invention is not particularly limited, but for example, solid preparations such as tablets, powders, fine granules, granules, capsules, pills, solutions, suspensions, syrups, emulsions Oral administration agents such as liquids. This orally administered agent includes excipients, disintegrants, binders, lubricants, surfactants, alcohols, water, water-soluble polymers, sweeteners, flavoring agents, It can be produced by a commonly used method by adding a sour agent, a pharmaceutical carrier and the like. The above-mentioned skin symptom is prevented or ameliorated by taking a skin symptom-improving medicine comprising a Cimicifuga racemosa extract as an active ingredient. The dosage of the skin symptom-improving drug may be 0.3 to 200 mg of Cimicifuga racemosa extract in dry weight per adult.

(製造例1)
シミシフーガ ラセモサ(Cimicifuga racemosa)の根茎5.2kgを50%含水エタノール10Lで抽出し、減圧濃縮した後乾燥し、445gの抽出物を得た。
(Production Example 1)
5.2 kg of rhizome of Cimicifuga racemosa was extracted with 10 L of 50% aqueous ethanol, concentrated under reduced pressure and dried to obtain 445 g of extract.

官能検査により、シミシフーガ ラセモサ(Cimicifuga racemosa)抽出物の肌症状改善効果を検討した。   The sensory test was conducted to examine the effect of Cimicifuga racemosa extract on improving skin symptoms.

乳糖を充填したカプセルをプラセボとし、製造例1で得られたシミシフーガ ラセモサ(Cimicifuga racemosa)抽出物粉末を充填したカプセルを被験物とした。   Capsules filled with lactose were used as placebos, and capsules filled with Cimicifuga racemosa extract powder obtained in Production Example 1 were used as test articles.

健常な20歳代、30歳代の女性21名をパネラーとし、プラセボを摂取したプラセボ群を10名(グループa)、シミシフーガ ラセモサ(Cimicifuga racemosa)抽出物を摂取したシミシフーガエキス群(グループb)を11名とした。   A panel of 21 women in their 20s and 30s who are healthy, 10 placebo groups that took placebo (Group a), and the Shimifuga extract group that took Cimicifuga racemosa extract (Group b) ) Was 11 persons.

シミシフーガエキスは、200mg/日、1日1回朝食後に28日間摂取した。プラセボ群、シミシフーガ群とも期間中の暴飲暴食を避け、市販のサプリメント等の摂取は控えさせた。   The shimifuga extract was taken at 200 mg / day, once daily, for 28 days after breakfast. In both the placebo group and the Shimifuga group, overdrinking and overeating were avoided during the period, and intake of commercial supplements was refrained.

二重盲検の並行2群間比較試験で官能検査を行った。被験物は摂取開始日(月曜日)から28日間毎朝継続摂取させた。摂取開始日および摂取期間中の毎水曜日と土曜日にアンケート(図1参照)を実施した。その結果を図2〜図7に示す。   A sensory test was performed in a double-blind parallel two-group comparative test. The test substance was continuously ingested every morning for 28 days from the intake start date (Monday). A questionnaire (see FIG. 1) was conducted on every intake day and every Wednesday and Saturday during the intake period. The results are shown in FIGS.

朝の肌の印象の「しっとり感」、「さっぱり感」、「べたつき感」において、シミシフーガエキス群(グループb)の摂取前後で有意なスコア改善が確認されたが、プラセボ群(グループa)に変化は確認されなかった。更に「しっとり感」については、摂取最終日のシミシフーガエキス群(グループb)の値がプラセボ群(グループa)と比較して有意に改善された。   In the morning skin impression of `` moist feeling '', `` freshness '', and `` stickiness '', a significant score improvement was confirmed before and after ingestion of the Shimisifuga extract group (Group b), but the placebo group (Group a) ) Was not confirmed. Furthermore, regarding “moist feeling”, the value of the Shimisifuga extract group (group b) on the last intake day was significantly improved compared to the placebo group (group a).

肌の経時変化の「かさつき」、「毛穴」、「吹き出物」、「肌のかたさ」、「肌のキメ」、「ベタつき」において、シミシフーガエキス群(グループb)で摂取前と比較して有意なスコア改善が確認されたが、プラセボ群(グループa)に変化は確認されなかった。更に「かさつき」、「ベタつき」については、摂取20日目以降のシミシフーガエキス群(グループb)の値がプラセボ群(グループa)と比較して有意に改善された。   Compared with pre-ingestion in the Shimifuga extract group (Group b) in the skin changes over time of “skininess”, “pores”, “pimples”, “skinness”, “skin texture”, and “stickiness” Although significant score improvement was confirmed, no change was observed in the placebo group (group a). Furthermore, with regard to “Katsutsuki” and “Smooth”, the value of the Shimifuga extract group (Group b) after the 20th day of ingestion was significantly improved compared to the placebo group (Group a).

本発明の肌症状改善剤、それを含むサプリメント、食品、飲料及び医薬は、シミシフーガ ラセモサ(Cimicifuga racemosa)抽出物を有効成分として含有することにより、安全性が高く、優れた肌症状改善作用が発揮されるので、極めて有用である。   The skin symptom improving agent of the present invention, supplements containing the same, foods, beverages and medicines contain a Cimicifuga racemosa extract as an active ingredient, which is highly safe and exhibits an excellent skin symptom improving action. Is extremely useful.

アンケート。questionnaire. 「顔全体の感触」、「しっとり感」、「さっぱり感」のアンケートの平均値の1ヶ月の経時変化を示すグラフ、横軸は日数を示す。A graph showing the change over time of one month of the average values of the questionnaires of “feel of the whole face”, “moist feeling”, and “freshness”, and the horizontal axis shows the number of days. 「べたつき感」、「お化粧のノリ」のアンケートの平均値の1ヶ月の経時変化を示すグラフ、横軸は日数を示す。A graph showing the change over time of one month in the average value of the questionnaire of “stickiness” and “makeup paste”, and the horizontal axis shows the number of days. 「かさつき感」、「くすみ」、「毛穴」のアンケートの平均値の1ヶ月の経時変化を示すグラフ、横軸は日数を示す。A graph showing the change over time of one month of the average value of the questionnaire for “feeling of bulkiness”, “dullness”, and “pores”, and the horizontal axis indicates the number of days. 「シミ・ソバカス」、「しわ」、「透明感」のアンケートの平均値の1ヶ月の経時変化を示すグラフ、横軸は日数を示す。A graph showing the change over time of one month of the average value of the questionnaire for “spots and freckles”, “wrinkles”, and “transparency”, and the horizontal axis indicates the number of days. 「吹き出物」、「肌のかたさ」、「肌のキメ」のアンケートの平均値の1ヶ月の経時変化を示すグラフ、横軸は日数を示す。A graph showing the changes over time of one month of the average values of the questionnaires of “pimples”, “skin softness”, and “skin texture”, and the horizontal axis indicates the number of days. 「張り・弾力」、「べたつき」のアンケートの平均値の1ヶ月の経時変化を示すグラフ、横軸は日数を示す。A graph showing the change over time of one month of the average value of the questionnaire of “tension / elasticity” and “stickiness”, and the horizontal axis shows the number of days.

Claims (6)

シミシフーガ ラセモサ(Cimicifuga racemosa)抽出物を有効成分として含有することを特徴とする肌症状改善剤。 A skin symptom improving agent characterized by containing an extract of Cimicifuga racemosa as an active ingredient. シミシフーガ ラセモサ(Cimicifuga racemosa)抽出物を配合したことを特徴とする肌症状改善用サプリメント。 A skin symptom improvement supplement characterized by containing Cimicifuga racemosa extract. シミシフーガ ラセモサ(Cimicifuga racemosa)抽出物を配合したことを特徴とする肌症状改善用食品。 A skin symptom-improving food characterized by containing an extract of Cimicifuga racemosa. シミシフーガ ラセモサ(Cimicifuga racemosa)抽出物を配合したことを特徴とする肌症状改善用飲料。 A skin symptom-improving beverage characterized by containing an extract of Cimicifuga racemosa. シミシフーガ ラセモサ(Cimicifuga racemosa)抽出物を配合したことを特徴とする皮膚化粧料。 A skin cosmetic characterized by containing an extract of Cimicifuga racemosa. シミシフーガ ラセモサ(Cimicifuga racemosa)抽出物を有効成分として含有することを特徴とする肌症状改善用医薬。 A medicament for improving skin symptoms, comprising an extract of Cimicifuga racemosa as an active ingredient.
JP2006063727A 2006-03-09 2006-03-09 Agent for ameliorating skin symptom, supplement, food, beverage and pharmaceutical for ameliorating skin symptom containing the same Withdrawn JP2007238509A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2006063727A JP2007238509A (en) 2006-03-09 2006-03-09 Agent for ameliorating skin symptom, supplement, food, beverage and pharmaceutical for ameliorating skin symptom containing the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2006063727A JP2007238509A (en) 2006-03-09 2006-03-09 Agent for ameliorating skin symptom, supplement, food, beverage and pharmaceutical for ameliorating skin symptom containing the same

Publications (1)

Publication Number Publication Date
JP2007238509A true JP2007238509A (en) 2007-09-20

Family

ID=38584392

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006063727A Withdrawn JP2007238509A (en) 2006-03-09 2006-03-09 Agent for ameliorating skin symptom, supplement, food, beverage and pharmaceutical for ameliorating skin symptom containing the same

Country Status (1)

Country Link
JP (1) JP2007238509A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009036751A3 (en) * 2007-09-19 2009-06-04 Bionorica Ag Cosmetic or dermatological composition for topical application
JP2010143862A (en) * 2008-12-19 2010-07-01 Sunstar Inc Composition containing plant extract
JP2012530691A (en) * 2009-06-21 2012-12-06 パラファーム インターナショナル (エイチケイ) リミテッド Method for isolating Shimiracemart A
JPWO2012115026A1 (en) * 2011-02-21 2014-07-07 キッコーマン株式会社 Tomatoside A-containing composition

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009036751A3 (en) * 2007-09-19 2009-06-04 Bionorica Ag Cosmetic or dermatological composition for topical application
JP2010143862A (en) * 2008-12-19 2010-07-01 Sunstar Inc Composition containing plant extract
JP2012530691A (en) * 2009-06-21 2012-12-06 パラファーム インターナショナル (エイチケイ) リミテッド Method for isolating Shimiracemart A
JPWO2012115026A1 (en) * 2011-02-21 2014-07-07 キッコーマン株式会社 Tomatoside A-containing composition
JP6042800B2 (en) * 2011-02-21 2016-12-14 キッコーマン株式会社 Tomatoside A extraction method

Similar Documents

Publication Publication Date Title
KR20080030633A (en) Method of treatment or management of stress
DK2010012T3 (en) APPLICATION OF A SAFETY EXTRACT AS A Saturation Agent For Overweight Treatment
JP4666537B1 (en) Wrinkle improving beauty set and beauty method using the same
JP2009263275A (en) Antioxidant and cosmetic product, food and drink composition and pharmaceutical composition containing the same
EP3248475A1 (en) Composition
JP2005000161A (en) Fermentation composition of cayenne pepper or capsaicinoid-containing plant
US20090269424A1 (en) Peripheral blood flow-improving composition
WO2017154865A1 (en) Ameliorating agent for female-specific physical and/or mental unpleasant symptom
JP2002293736A (en) Maillard reaction inhibitor and composition containing the same
KR20210113716A (en) Composition for preventing, alleviating, improving, or treating the female hormone controlling disorder syndrome or symptoms comprising green tea extract which has modified amounts of ingredients
TWI586376B (en) Skin improvement methods and methods to promote collagen production
JP2005015456A (en) Prophylactic and therapeutic agent for eczema/dermatitis group
JP2007238509A (en) Agent for ameliorating skin symptom, supplement, food, beverage and pharmaceutical for ameliorating skin symptom containing the same
WO2005094859A1 (en) Agent improving moisture-retention function of skin
KR101157535B1 (en) Composition for improving atopic dermatitis
JP6084468B2 (en) Sterile mild sustained saliva secretion promoter, method for producing the same, and milder mild saliva secretion promoting food
JP5004529B2 (en) Histamine release inhibitor
JP4906282B2 (en) Melanin production inhibitor
JP2007070263A (en) Composition for preventing diabetes mellitus
JP6141071B2 (en) Skin moisture increasing agent
JP5582593B2 (en) Platelet aggregation inhibitor
JP2005089374A (en) Food and drink having function for preventing increase in blood glucose level
JP4359046B2 (en) Anti-stress agent
JP4542765B2 (en) Enzyme inhibitor
JP4768105B2 (en) Oral composition

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20081114

A761 Written withdrawal of application

Free format text: JAPANESE INTERMEDIATE CODE: A761

Effective date: 20091027